BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27283082)

  • 1. Progress and Prospects in Pediatric Leukemia.
    Madhusoodhan PP; Carroll WL; Bhatla T
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):229-241. PubMed ID: 27283082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features, molecular diagnosis, and treatment outcome of infants with leukemia in Taiwan.
    Chen SH; Yang CP; Hung IJ; Jaing TH; Shih LY; Tsai MH
    Pediatr Blood Cancer; 2010 Dec; 55(7):1264-71. PubMed ID: 20979094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the understanding and treatment of pediatric leukemias.
    Maloney KW; Giller R; Hunger SP
    Adv Pediatr; 2012; 59(1):329-58. PubMed ID: 22789585
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukemia.
    McKenna SJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):137-9. PubMed ID: 10673646
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug development: target practice.
    Katsnelson A
    Nature; 2013 Jun; 498(7455):S8-9. PubMed ID: 23803950
    [No Abstract]   [Full Text] [Related]  

  • 8. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
    Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
    Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
    [No Abstract]   [Full Text] [Related]  

  • 9. Consistent genetic abnormalities in human cancers as targets for selective therapies.
    Clarkson BD
    Mt Sinai J Med; 1992 Oct; 59(5):400-4. PubMed ID: 1435835
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukemias.
    Pejovic T; Schwartz PE
    Clin Obstet Gynecol; 2002 Sep; 45(3):866-78. PubMed ID: 12370628
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
    Savchenko VG; Isaev VG; Abakumov EM; Khoroshko ND; Turkina AG; Sokolov AN; Viadro MM; Navashin SM
    Antibiot Khimioter; 1992 Jul; 37(7):47-9. PubMed ID: 1456812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
    Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The childhood leukemias.
    Colby-Graham MF; Chordas C
    J Pediatr Nurs; 2003 Apr; 18(2):87-95. PubMed ID: 12720205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetic study of acute and chronic leukemias].
    Conte G; Torrens M; Larraín C; Be C; Daher V; Youlton R
    Rev Med Chil; 1989 Feb; 117(2):135-41. PubMed ID: 2487950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute lymphoblastic Ph1-positive leukemia with a hybrid phenotype. The significance of the Ph1 anomaly and the hybrid phenotype].
    Nicoară S; Stefănescu D; Roman S; Tudor F; Butoianu E; Ursea C; Petrescu A; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(1):85-9. PubMed ID: 2573927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion chemotherapy with epirubicin and vincristine in relapsed and refractory acute leukemia.
    Liso V; Specchia G; Pavone V; Capalbo S; Dione R
    Acta Haematol; 1990; 83(3):116-9. PubMed ID: 2109448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress in the treatment of acute leukemia].
    Kimura Y
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute leukemia in childhood. Classification--diagnosis--therapy--prognosis].
    Creutzig U; Schrappe M
    Internist (Berl); 1996 Oct; 37(10):982-93. PubMed ID: 9019456
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome after cessation of therapy in childhood leukemia. A population-based Nordic study of 986 patients.
    Nygaard R; Moe PJ
    Acta Paediatr Scand Suppl; 1989; 354():1-24. PubMed ID: 2596294
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative evaluation of response to intensive chemotherapy in acute leukaemic patients.
    Mód A; Tamáska J; Poros A; Király A; Adám E; Gidáli J; Hollán SR
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():24. PubMed ID: 2627605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.